Critical Care · Pulmonology
Mechanical Ventilation — ARDS
ARDSnet Lung-Protective Ventilation · FiO₂/PEEP Table · Driving Pressure · Prone Positioning
🫁 Berlin Definition of ARDS (JAMA 2012)
Mild
200–300
PaO₂/FiO₂ on PEEP/CPAP ≥5 cmH₂O
Moderate
100–200
PaO₂/FiO₂ on PEEP ≥5 cmH₂O
Severe
<100
PaO₂/FiO₂ on PEEP ≥5 cmH₂O
Required: Acute onset (<1 week) · Bilateral opacities on CXR/CT · Respiratory failure not fully explained by fluid overload or cardiac failure · PaO₂/FiO₂ ratio as above on PEEP ≥5
⚙️ ARDSnet Lung-Protective Initial Ventilator Settings
ParameterTarget / SettingRationale
ModeVolume Control AC (VC-AC)Ensures consistent tidal volume delivery
Tidal Volume (Vt)6 mL/kg IBW (range 4–8 mL/kg)ARDSnet trial: reduced mortality vs 12 mL/kg
Respiratory Rate14–35 breaths/minTitrate to maintain pH goal; avoid air trapping
PEEP5–24 cmH₂O (per FiO₂/PEEP table)Alveolar recruitment; prevent derecruitment
Plateau Pressure (Pplat)≤30 cmH₂OLimits barotrauma; check every 4h and after changes
Driving Pressure (ΔP)≤15 cmH₂O (ΔP = Pplat − PEEP)ΔP >15 independently predicts mortality (Amato 2015)
I:E Ratio1:1 to 1:3Allow adequate expiration; avoid auto-PEEP
FiO₂0.3–1.0 (per table below)Titrate to SpO₂ 88–95%, PaO₂ 55–80 mmHg
pH Target7.30–7.45Permissive hypercapnia accepted (pH >7.20)
PaO₂ Target55–80 mmHgSpO₂ 88–95% acceptable in ARDS
📊 ARDSnet FiO₂/PEEP Combination Table
Lower PEEP Strategy
FiO₂0.30.40.50.60.70.80.91.0
PEEP55–88–101010–141414–1818–24
Higher PEEP Strategy (Moderate–Severe)
FiO₂0.30.40.50.60.70.80.91.0
PEEP5–1414–1616–1820222222–2422–24
🔄 Prone Positioning (PROSEVA 2013)
Indication: PaO₂/FiO₂ <150 mmHg on FiO₂ ≥0.6, PEEP ≥5
Duration: ≥16 hours/day continuous sessions
Mortality benefit: 28-day mortality ↓ 32.8% vs 16%
Contraindications: unstable spine, elevated ICP, open abdomen, facial trauma, pregnancy (relative)
Complications: pressure sores, ETT displacement, facial edema
Revert to supine if PaO₂/FiO₂ >150 x 4h (PEEP ≤10, FiO₂ ≤0.6)
🆘 Rescue Therapies (Refractory Hypoxemia)
Inhaled Nitric Oxide (iNO): 5–40 ppm. Improves V/Q mismatch — no mortality benefit
Neuromuscular Blockade (NMB): Cisatracurium 37.5 mg/h; 48h course may reduce VILI in moderate-severe ARDS
Recruitment Maneuvers: Use cautiously — sustained inflation or CPAP 40 cmH₂O × 40 sec (risk: hemodynamic instability)
ECMO (VV): PaO₂/FiO₂ <80 despite optimization ≥3h, or uncompensated hypercapnia (pH <7.25)
Corticosteroids: Dexamethasone 20 mg/day × 5d → 10 mg × 5d may reduce ventilator days (DEXA-ARDS, 2020)
CCM Notes · FOAMed · Critical Care Clinical Reference
About
Based on ARDSnet NEJM 2000 / PROSEVA NEJM 2013 / Berlin 2012
Educational use only